Protalix Biotherapeutics Inc
PLX
$2.75+4.17%
Delayed · as of Sep 14, 2026, 11:30 AM ET
Mkt cap
$122.59M
EV/Sales
2.05
P/E ratio
N/A
FY2025 Revenue
$52.74M
EPS (H1 2026)
$0.27
Gross Margin (FY2025)
48.82%
Profit Margin (FY2025)
-12.52%
Beta
-0.22
Div yield
N/A
Sector
Healthcare
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported PLX revenue for 2025-12-31 was $52.7M. Net income was -$6.6M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. PLX currently screens at market cap $122.6M.
Use this PLX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PLX income, balance, and cash tables.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company in the Healthcare sector.
Latest cached Protalix Biotherapeutics Inc (PLX) revenue for Dec 31, 2025 was $52.7M. Net income was -$6.6M. Statements: https://lician.com/financials/plx
Protalix Biotherapeutics Inc (PLX) market capitalization is $122.6M on the latest cached snapshot.
Protalix Biotherapeutics Inc (PLX) cached previous close $2.64; day range $2.62 – $2.75; volume 280,758. Session quote: https://lician.com/quote/plx
Protalix Biotherapeutics Inc (PLX) latest cached earnings event is "PLX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PLX filing is 8-K · Aug 12, 2026. Filings: https://lician.com/sec/plx